| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 01/08/2002 | CA2159915C Systemic effects of nitric oxide inhalation |
| 01/03/2002 | WO2002000285A1 Method for curing drug dependence |
| 01/03/2002 | WO2002000244A2 Protein mixtures for wound healing |
| 01/03/2002 | WO2002000228A1 Oxygen-containing ophthalmic composition |
| 01/03/2002 | WO2002000227A2 Use of lanthanum compounds for the treatment of bone diseases |
| 01/03/2002 | WO2002000192A2 Embolization using carbon coated particles |
| 01/03/2002 | WO2002000190A1 Cosmetic and pharmaceutical compositions and methods using green-light emitting materials |
| 01/03/2002 | WO2002000175A2 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 01/03/2002 | WO2002000170A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | WO2001070242A3 Compositions containing molecular iodine |
| 01/03/2002 | WO2001035935A3 Inhibitors of endo-exonuclease activity such as pentamidine for the treatment of cancer |
| 01/03/2002 | US20020002353 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
| 01/03/2002 | US20020001630 Angiogenesis inhibitor |
| 01/03/2002 | US20020001629 Pretreatment; inducing stress response |
| 01/03/2002 | US20020001628 Pharmaceutical composition for preventing and/or curing digestive disorders |
| 01/03/2002 | US20020001608 Biodegradable implant precursor |
| 01/03/2002 | US20020001575 Nutritional system for nervous system disorders |
| 01/03/2002 | CA2414409A1 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 01/03/2002 | CA2414401A1 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | CA2413338A1 Protein mixtures for wound healing |
| 01/02/2002 | EP1166789A2 Arsenolite containing angiogenesis inhibitor |
| 01/02/2002 | EP1166788A1 Remedies for joint diseases |
| 01/02/2002 | EP1166787A2 Stable amino acid based bicarbonate solutions for peritoneal dialysis and hemodialysis |
| 01/02/2002 | EP1166291A1 Heating of magnetic material by hysteresis effects |
| 01/02/2002 | EP1165041A1 Antimicrobial wipes which provide improved immediate germ reduction |
| 01/02/2002 | EP0600079B1 Oral 1alpha-hydroxyprevitamin d |
| 01/02/2002 | CN1329465A Baby food stimulating growth of the thymus |
| 01/02/2002 | CN1328844A Liquid Chinese medicine for curing hemorrhoid complicated by anal fistula |
| 01/02/2002 | CN1328840A Medicated bag for curing tussis |
| 01/02/2002 | CN1328827A Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
| 01/02/2002 | CN1328826A Injection for curing primary varix of lower limb |
| 01/02/2002 | CN1328819A Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
| 01/02/2002 | CN1328815A Sunscreen compound containing basic component 4,4'-diarylbutadiene as uvioresistant light-filtering agent in cosmetics and medicine preparation |
| 01/02/2002 | CN1076971C Powder for removing infantile malnutrition |
| 01/01/2002 | US6335457 Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex |
| 01/01/2002 | US6335194 Antisense modulation of survivin expression |
| 12/29/2001 | CA2342059A1 Angiogenesis inhibitor |
| 12/27/2001 | WO2001097849A1 Antitumor effect potentiators |
| 12/27/2001 | WO2001097826A2 Hemostatic compositions, devices and methods |
| 12/27/2001 | WO2001097815A2 Use of glucocorticosteroids for producing a medicament to treat oligotrichia |
| 12/27/2001 | WO2001097802A1 Supplement to enhance fertility |
| 12/27/2001 | WO2001097790A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 12/27/2001 | WO2001097771A2 Preparations that contain an extract of the plant pistia stratiotes |
| 12/27/2001 | WO2001097750A2 Method for producing an antiviral agent |
| 12/27/2001 | WO2001062086A8 Nutritional intervention composition for enhancing and extending satiety |
| 12/27/2001 | US20010056127 Contains molecular iodine in a concentration above at least 15 ppm and one of triiodide or complexed iodoine may be present; lower concentrations of iodine disinfect without staining skin |
| 12/27/2001 | US20010056068 Such as atherosclerosis, restenosis, hypertension, preeclampsia and/or intrauterine fetal growth retardation, infection, SLE-lupus, anaphylactic reaction, allograft rejection, hormone replacement therapy, Alzheimer's disease |
| 12/27/2001 | US20010056062 As osmotic agents synthetic polypeptides of two to fifteen amino acids long; slow transport across the peritoneum, for prolonged osmotic gradient between dialysate and blood |
| 12/27/2001 | US20010055623 Dietary supplements |
| 12/27/2001 | US20010055622 Antimicrobial bioabsorbable materials |
| 12/26/2001 | CN1328467A Buffered composition for dialysis |
| 12/26/2001 | CN1328456A Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 12/26/2001 | CN1327846A Medicine for treating throat diseases and its preparing process |
| 12/26/2001 | CN1327833A Exterior-applied ointment for treating piles |
| 12/26/2001 | CN1327831A Chinese medicine for treating tinea and antipruritic |
| 12/26/2001 | CN1327818A Antiabortifacient for treating acyesis and sterility and its preparing process |
| 12/26/2001 | CN1327807A Chinese medicine for treating neoplasm |
| 12/26/2001 | CN1327806A Compound Cijin capsule |
| 12/26/2001 | CN1327800A Composite Chinese medicine for treating prostatitis, impotence and ejaculation praecox and its preparing process |
| 12/26/2001 | CN1076619C Moxiburning medicine for acupoint therapy |
| 12/26/2001 | CN1076615C Chinese medicine powder for setting bone |
| 12/26/2001 | CN1076610C Mongolia patent drug for treating peptide ulcer |
| 12/25/2001 | US6333306 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 12/25/2001 | US6333193 Aggregation propagation catalyst; for use in culturing of cells |
| 12/25/2001 | US6333055 Use of ammonium compounds and/or urea |
| 12/25/2001 | US6333054 Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 12/20/2001 | WO2001095920A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy |
| 12/20/2001 | WO2001095895A2 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| 12/20/2001 | WO2001095863A2 Compositions for treating tooth and/or bone tissue |
| 12/20/2001 | WO2001066102A3 Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same |
| 12/20/2001 | WO2001064164A3 Nanocapsule encapsulation system and method |
| 12/20/2001 | WO2001052796A3 Methods of using a beverage composition for treating dental erosion |
| 12/20/2001 | US20010053389 Method for management of blood glucose levels |
| 12/20/2001 | CA2450806A1 Compositions for treating tooth and/or bone tissue |
| 12/20/2001 | CA2415369A1 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity |
| 12/20/2001 | CA2412843A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy |
| 12/19/2001 | EP1164138A1 Terpyridine-platinum (II) complexes |
| 12/19/2001 | EP1164132A2 Crystalline magnesium omeprazole |
| 12/19/2001 | EP1163904A1 Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
| 12/19/2001 | EP1163528A2 Prediction of diabetes impaired wound healing |
| 12/19/2001 | EP1163247A1 Pharmaceutical compositions comprising metal complexes |
| 12/19/2001 | EP1162890A1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
| 12/19/2001 | EP1128726A4 Teat disinfectant |
| 12/19/2001 | CN1326781A Varicosis contraction medicine and its preparing method |
| 12/19/2001 | CN1326779A Chunren liver recovering capsule |
| 12/19/2001 | CN1326777A Medicinal bag for preventing cold |
| 12/19/2001 | CN1076195C Compound containing zinc and composition of p-acetaminophenyl acetic acid |
| 12/19/2001 | CN1076164C Compositions and uses thereof |
| 12/18/2001 | US6331551 Cosmetic formulation for treating skin disorder caused by microbial infection, comprising sclareol-like or sclareolide-like compound in cosmetically acceptable carrier |
| 12/18/2001 | US6331514 Sterilizing and disinfecting compound |
| 12/18/2001 | CA2074215C Improved oral dosing formulations of dideoxy purine nucleosides |
| 12/18/2001 | CA2063610C Method for the treatment of aging or photo-damaged skin |
| 12/13/2001 | WO2001093909A2 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor |
| 12/13/2001 | WO2001093879A1 Biologically active agents and drugs |
| 12/13/2001 | WO2001093878A2 Bismuth compounds for the treatment and prevention of mucositis |
| 12/13/2001 | WO2001093877A2 Epithelial cell cancer drug |
| 12/13/2001 | WO2001093858A2 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria |
| 12/13/2001 | WO2001093856A1 Medical composition kit for treating lesioned abnormal tissue |
| 12/13/2001 | WO2001093847A2 Compositions, kits, and methods for promoting defined health benefits |
| 12/13/2001 | WO2001093830A1 Method for obtaining aqueous formulations of oxidation-sensitive active principles |